Delivery Methods Compared for Osteoarthritis Intervention
TUESDAY, Nov. 8, 2022 (HealthDay News) — First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 in JAMA Network Open.Therese Jönsson, Ph.D., f…
Learn MoreHip Brace May Slow Hip Displacement in Children With Cerebral Palsy
TUESDAY, Nov. 8, 2022 (HealthDay News) — A novel hip brace is significantly effective in preventing the progression of hip displacement among children with nonambulatory cerebral palsy, according to a study published online Nov. 4 in JAMA Network Ope…
Learn MoreVaginal Progesterone Not Tied to Reduction in Recurrent Preterm Birth
TUESDAY, Nov. 8, 2022 (HealthDay News) — Use of vaginal progesterone is not associated with a reduction in recurrent preterm birth, according to a study published online Oct. 31 in JAMA Network Open.David B. Nelson, M.D., from the University of Texas…
Learn MoreMore Youth Seeking Care for Eating Disorders During Pandemic
TUESDAY, Nov. 8, 2022 (HealthDay News) — There was a significant increase in adolescents and young adults seeking inpatient and outpatient care for eating disorders after the onset of the COVID-19 pandemic, according to a study published online Nov….
Learn MoreAmerican Society for Radiation Oncology, Oct. 23-26
The annual meeting of the American Society for Radiation Oncology was held from Oct. 23 to 26 in San Antonio and attracted approximately 11,000 participants from around the world, including physicians, oncology nurses, radiation therapists, biologist…
Learn MoreLipid-Lowering, Antidiabetic Drugs Tied to Prevalence of AMD
TUESDAY, Nov. 8, 2022 (HealthDay News) — Lipid-lowering drugs (LLDs) and antidiabetic drugs are associated with lower prevalence of any age-related macular degeneration (AMD), according to a meta-analysis published online Nov. 7 in the British Journa…
Learn MoreTelmisartan Linked to Reduced Risk for Alzheimer Disease in Black Patients
MONDAY, Nov. 7, 2022 (HealthDay News) — In African American patients, telmisartan is associated with a reduced risk for Alzheimer disease (AD), according to a study published online Nov. 4 in Alzheimer’s & Dementia.Pengyue Zhang, Ph.D., from Indiana …
Learn MoreENT-01 Safe, Improves Constipation in Patients With Parkinson Disease
MONDAY, Nov. 7, 2022 (HealthDay News) — Oral ENT-01, which inhibits the formation of α-synuclein aggregation, is safe and improves constipation among patients with Parkinson disease (PD) and constipation, according to a study published online Nov. 8 …
Learn MoreMonkeypox Infection Rare in Children, Adolescents Younger Than 18
MONDAY, Nov. 7, 2022 (HealthDay News) — Monkeypox infection is rare among children and adolescents, and infections are usually not severe, according to research published in the Nov. 4 issue of the U.S. Centers for Disease Control and Prevention Mor…
Learn MoreSecond, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
MONDAY, Nov. 7, 2022 (HealthDay News) — Exposure to a second or third dose of COVID-19 vaccine is associated with an increased risk for relapse for adults with glomerular disease, according to a study published online Nov. 3 in the Journal of the Ame…
Learn More